Angiotensin II type I receptor blocker, Losartan, inhibits fibrosis in liver by suppressing TGF-beta1 production. Issue 1 (2016)

Record Type:
Journal Article
Title:
Angiotensin II type I receptor blocker, Losartan, inhibits fibrosis in liver by suppressing TGF-beta1 production. Issue 1 (2016)
Main Title:
Angiotensin II type I receptor blocker, Losartan, inhibits fibrosis in liver by suppressing TGF-beta1 production
Authors:
Ogata, Hisanobu
Noguchi, Hideko
Ohtsubo, Toshio
Liao, Jiyuan
Kohara, Hiroshi
Yamada, Kazunari
Murahashi, Mutsunori
Hijikata, Yasuki
Suetsugu, Atsushi
Hoffman, Robert M
Tani, Kenzaburo
Is Part Of:
Integrative molecular medicine. Volume 3:Issue 1(2016:Feb.)
Journal:
Integrative molecular medicine
Issue:
Volume 3:Issue 1(2016:Feb.)
Issue Display:
Volume 3, Issue 1 (2016)
Year:
2016
Volume:
3
Issue:
1
Issue Sort Value:
2016-0003-0001-0000
Page Start:
Page End:
Publication Date:
2016
Subjects:
Pathology, Molecular -- Periodicals
Molecular biology -- Periodicals
616.042
Journal URLs:
http://oatext.com/IntegrativeMolecularMedicine-currentissue.php ↗
DOI:
↗
Languages:
English
ISSNs:
2056-6360
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library HMNTS - ELD Digital store
Ingest File:
14194.xml